Acorda Therapeutics Inc. (ACOR)’s stock is trading at $0.43 at the moment marking a fall of -4.44% from the last session close. As of this writing, shares are priced at -91.38% less than their 52-week high of $4.99, and 55.66% over their 52-week low of $0.28. Based on the past 30-day period, the stock price is -21.60% below the high and +5.76% above the low.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ACOR’s SMA-200 is $1.9192.
As an additional measure, we should look at the company’s price-to-sales ratio for the past year, which is 0.05 at the moment.
How does Acorda Therapeutics Inc. (ACOR) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a No Ratings. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.
Acorda Therapeutics Inc. (ACOR): Earnings History
If we examine Acorda Therapeutics Inc.’s recent earnings history, in the last quarter ended on 9/29/2021, it posted adjusted earnings per share of -$1.43, slashing the consensus of -$1.56. In other words, it beat the consensus by $0.13, resulting in a 8.30% surprise. In the 3 months period before the previous quarter which was closed on 9/29/2021, the stock recorded adjusted earnings per share of -$1.43 in contrast with the Outlook of -$1.56. That was a difference of $0.13 and a surprise of 8.30%.
Acorda Therapeutics Inc. (ACOR): Earnings History
Most analysts expect public companies to report earnings and revenue in line with their projections, but sometimes these figures vary from what they actually expected. In the current quarter, the company had earnings predictions made by 1 different analysts, who are expecting earnings to fall in between the range of -0.36 and -0.36 with an average Earnings Estimate of -0.36 which is in contrast with the last year earnings estimate of -2.29 and also replicates 84.28% growth rate year over year.
Acorda Therapeutics Inc. (NASDAQ: ACOR) Ownership Details
I will give a breakdown of the key shareholders in Acorda Therapeutics Inc. (ACOR). Recent figures show that the company’s insiders hold 1.33% of shares. A total of 46 institutional investors hold shares in the company, making 43.63% of its stock and 44.21% of its float.
Mar 30, 2022, it was reported that the Company’s largest institutional holder is Renaissance Technologies, LLC holding total of 0.71 million shares that make 5.32% of the company’s total number of shares and are currently priced at 0.3 million.
The securities firm Canyon Capital Advisors LLC holds 0.65 million shares of ACOR, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 4.89%, and the holding percentage of shares is valued at 0.28 million.
An overview of Acorda Therapeutics Inc.’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Acorda Therapeutics Inc. (ACOR) traded 326,840 shares per day, with a moving average of $0.4596 and price change of -0.06. With the moving average of $0.4705 and a price change of -0.22, about 2,203,970 shares changed hands on average over the past 50 days. Finally, ACOR’s 100-day average volume is 1,135,667 shares, alongside a moving average of $1.0173 and a price change of -1.70.
